An Interview with Mrs Kenalee Patel, Quality Assurance-Operations Department at Zydus-Hospira Oncology Pvt. Ltd. Kumar Jeetendra | January 4, 2022 Ms Kenalee Patel is Heading Quality Assurance – Operations Department at Zydus-Hospira Oncology Pvt. Ltd. in Sanand, Ahmedabad is one of the leading businesses in the Pharmaceutical Manufacturers. Here I am sharing an interesting line of interaction with Mrs Kenalee Patel. Can you tell me a little about yourself? A:I am born and bought up …
Alembic Pharmaceuticals receives USFDA Final Approval for Entacapone Tablets USP, 200 mg. Kumar Jeetendra | January 6, 2022 6th January, 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Entacapone Tablets USP, 200 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Comtan Tablets, 200 mg, of …
Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. Kumar Jeetendra | March 8, 2022 8th March 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The approved ANDA is therapeutically equivalent to the reference …
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions Kumar Jeetendra | March 10, 2022 Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD). “We have established an approach that transforms real-world, in-human treatment outcomes and …
Alembic Pharmaceuticals receives USFDA Tentative Approval for Macitentan Tablets, 10 mg. Kumar Jeetendra | March 14, 2022 14th March 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Opsumit Tablets, 10 mg, of …
Top 10 Indian origin, BA/BE CROs to look upon in 2022 Kumar Jeetendra | April 2, 2022 The key to making profits in the generic drug market is reaching the market as early as possible by getting proper regulatory approval. Generic medicines play an essential role in the pharmaceutical market because of their lower cost than branded drug molecules. Manufacturers of Generic Pharmaceuticals need not begin from scratch and carry out R&D, …
Compact Multi-position Reactor Kit for Low Temperature Chemistry Kumar Jeetendra | April 5, 2022 Asynt has introduced a versatile new kit for labs conducting low temperature chemistry – the DrySyn SnowStorm MULTI Starter Kit. developed as a useful addition to Asynt’s popular low temperature chemistry product range – the DrySyn SnowStorm MULTI Starter Kit enables users to perform parallel reactions from ambient to -30 ⁰C within a small footprint. …
Alembic Pharmaceuticals announces USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg. Kumar Jeetendra | April 7, 2022 7th April, 2022, Mumbai: Alembic Pharmaceuticals Limited today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) …
Cipla Launches ‘RT Direct’ Multiplex real time PCR kit for Covid-19 RNA extraction free kit to deliver results in just 45 Min Kumar Jeetendra | May 10, 2022 Mumbai, India; May 10, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India, in partnership with Genes2Me Pvt. Ltd. With this, Cipla is expanding its diagnostics offering to bring more advanced and innovative products. Cipla will be responsible …
Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka Kumar Jeetendra | June 3, 2022 India; June 2, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the commercial operation of additional capacity of captive renewable energy power plant in Maharashtra & Karnataka. In Jan’21, Cipla had commissioned 30 MWp solar project at Tuljapur, and now further added 16 MWp of solar capacity for supplying …
Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label- Free Bioanalytics Kumar Jeetendra | July 4, 2022 The Life Science Group Sartorius today launched the new Octet® SF3, the first Surface Plasmon Resonance (SPR) system under the Sartorius Octet® brand. Up to now, the Octet® name has been synonymous with Bio-Layer Interferometry (BLI), a proprietary fluidic-free instrument platform for real- time, label-free analysis of biomolecular interactions. This launch establishes Sartorius as the …
Fast Tracking Flowmeter Design for the Measurement of Fuel Consumption Kumar Jeetendra | July 7, 2022 With increasing fuel prices, all sectors of the transport industry, from small trucks to larger super-tankers, are taking an interest in effective ways of measuring their vehicle’s fuel consumption and hydraulic oil flow. Unfortunately, it’s not a simple task! Engine fuel consumption and efficiency generally goes unmonitored, the performance of a diesel power unit assessed …
